ATE91285T1 - Reinigung und aktivierung von proteinen aus unloeslichen einschlussteilchen. - Google Patents

Reinigung und aktivierung von proteinen aus unloeslichen einschlussteilchen.

Info

Publication number
ATE91285T1
ATE91285T1 AT86306353T AT86306353T ATE91285T1 AT E91285 T1 ATE91285 T1 AT E91285T1 AT 86306353 T AT86306353 T AT 86306353T AT 86306353 T AT86306353 T AT 86306353T AT E91285 T1 ATE91285 T1 AT E91285T1
Authority
AT
Austria
Prior art keywords
protein
solution
purification
sds
exchange column
Prior art date
Application number
AT86306353T
Other languages
English (en)
Inventor
Steven K Rausch
Original Assignee
Imcera Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imcera Group Inc filed Critical Imcera Group Inc
Application granted granted Critical
Publication of ATE91285T1 publication Critical patent/ATE91285T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT86306353T 1985-08-19 1986-08-18 Reinigung und aktivierung von proteinen aus unloeslichen einschlussteilchen. ATE91285T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/767,032 US4766224A (en) 1985-08-19 1985-08-19 Purification and activation of proteins from insoluble inclusion bodies
EP86306353A EP0212960B1 (de) 1985-08-19 1986-08-18 Reinigung und Aktivierung von Proteinen aus unlöslichen Einschlussteilchen

Publications (1)

Publication Number Publication Date
ATE91285T1 true ATE91285T1 (de) 1993-07-15

Family

ID=25078290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86306353T ATE91285T1 (de) 1985-08-19 1986-08-18 Reinigung und aktivierung von proteinen aus unloeslichen einschlussteilchen.

Country Status (13)

Country Link
US (1) US4766224A (de)
EP (1) EP0212960B1 (de)
AT (1) ATE91285T1 (de)
BR (1) BR8603944A (de)
CA (1) CA1267495A (de)
DE (1) DE3688663T2 (de)
DK (1) DK394786A (de)
ES (1) ES2000287A6 (de)
IE (1) IE61756B1 (de)
IL (1) IL79760A (de)
MX (1) MX168137B (de)
PT (1) PT83205B (de)
ZA (1) ZA866250B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
US4705848A (en) * 1986-06-02 1987-11-10 International Minerals & Chemical Corp. Isolation of bioactive, monomeric growth hormone
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
US5013653A (en) 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
CA1339757C (en) * 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
CA1305285C (en) * 1987-04-21 1992-07-14 Malcolm Roy Brandon Production of proteins in active forms
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5162507A (en) * 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
US4801691A (en) * 1987-05-15 1989-01-31 International Minerals & Chemical Corp. Method for removing sodium dodecyl sulfate from sodium dodecyl sulfate solubilized protein solutions
US6384194B1 (en) 1987-12-16 2002-05-07 Dsm N.V. Expression and purification of human interleukin-3 and muteins thereof
EP0325691B1 (de) * 1988-01-25 1993-04-07 Consortium für elektrochemische Industrie GmbH Verfahren zur Solubilisierung von unlöslichem Protein
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
US5136027A (en) * 1989-05-02 1992-08-04 Abbott Laboratories Method for renaturing proteins in the presence of alkyl sulfate detergents
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
US4975529A (en) * 1989-08-18 1990-12-04 Monsanto Company Method of folding somatotropins
US5530100A (en) * 1990-05-07 1996-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Methods for purification of recombinantly produced proteins
US5023323A (en) * 1990-09-12 1991-06-11 Monsanto Company Method of somatotropin naturation
US5605691A (en) * 1992-09-17 1997-02-25 Ophidian Pharmaceuticals, Inc. Immunologically active proteins from inclusion bodies
US5955087A (en) * 1995-02-24 1999-09-21 Cantab Pharmaceuticals Research Limited Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
EP0837883B1 (de) * 1995-06-07 2005-08-10 Chiron Corporation Methode zur lösung, reinigung und rückfaltung von protein
KR100374306B1 (ko) * 1995-07-14 2003-07-12 주식회사 엘지생명과학 재조합효모로부터과립구-콜로니자극인자를정제하는방법
ZA9711733B (en) * 1996-12-31 1998-07-01 Monsanto Co Method for solubilization and naturation of somatotropins
DE69839553D1 (de) 1997-01-08 2008-07-10 Invitrogen Corp Verfahren zur herstellung von proteinen
EP0988112B1 (de) * 1997-06-20 2010-04-14 New York University Elektrosprühen von lösungen zur massenherstellung von chips und molekülbibliotheken
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
AU4975699A (en) * 1998-07-09 2000-02-01 University Technology Corporation High pressure refolding of protein aggregates and inclusion bodies
EP1434789B1 (de) * 2000-10-31 2008-03-26 BaroFold, Inc. Verbesserter zerfall und rückfaltung von proteinen mittels hohen drucks
JP2009544974A (ja) 2006-07-21 2009-12-17 ライフ テクノロジーズ コーポレーション 鮮明に分解する標識タンパク質分子量標準
EP2059523A2 (de) * 2006-09-15 2009-05-20 Barofold, Inc. Hochdruckbehandlung von proteinen für reduzierte immunogenizität
AU2009256308A1 (en) * 2008-06-03 2009-12-10 Patrys Limited Process for purification of antibodies
SG178870A1 (en) * 2009-08-26 2012-04-27 Commw Scient Ind Res Org Processes for producing silk dope
CN102977183B (zh) * 2012-12-11 2016-08-17 鲁南新时代生物技术有限公司 一种基因工程包涵体的洗涤方法
CN113773371B (zh) * 2021-09-16 2024-06-18 北京凯悦宁医药科技有限公司 一种vp1蛋白及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4426323A (en) * 1980-01-10 1984-01-17 Ionics, Incorporated Selected recovery of proteins from fermentation broths
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4599197A (en) * 1982-12-22 1986-07-08 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GR79124B (de) * 1982-12-22 1984-10-02 Genentech Inc
IE56372B1 (en) * 1982-12-22 1991-07-03 Genentech Inc Microbially produced rennet methods for its production and plasmids used for its production
US4677196A (en) * 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies

Also Published As

Publication number Publication date
IL79760A (en) 1992-02-16
EP0212960A2 (de) 1987-03-04
DK394786D0 (da) 1986-08-19
PT83205B (pt) 1988-07-01
ZA866250B (en) 1987-03-25
PT83205A (en) 1986-09-01
CA1267495C (en) 1990-04-03
ES2000287A6 (es) 1988-02-01
EP0212960A3 (en) 1989-02-22
IE61756B1 (en) 1994-11-30
MX168137B (es) 1993-05-06
IL79760A0 (en) 1986-11-30
EP0212960B1 (de) 1993-07-07
DK394786A (da) 1987-02-20
CA1267495A (en) 1990-04-03
US4766224A (en) 1988-08-23
BR8603944A (pt) 1987-03-24
DE3688663D1 (de) 1993-08-12
IE862211L (en) 1987-02-19
DE3688663T2 (de) 1993-10-28

Similar Documents

Publication Publication Date Title
ATE91285T1 (de) Reinigung und aktivierung von proteinen aus unloeslichen einschlussteilchen.
DE3684078D1 (de) Reinigung und aktivierung von proteinen aus unloeslichen einschlusskoerpern.
DE3586762D1 (de) Gereinigtes rekombinantes interleukin-2 und verfahren zu dessen rueckgewinnung und reinigung.
ATE113960T1 (de) Proteingewinnung.
DE3687254D1 (de) Verfahren zur trennung von proteinen aus waesserigen loesungen.
GB1496726A (en) Fractionation of proteins by electrical means
KR940027658A (ko) 트롬빈 결합성 물질 및 이의 제조방법
ATE26986T1 (de) Verfahren zur loesung von peptiden und proteinen, hierdurch erhaltene loesungen und deren verwendung.
GB1401737A (en) Anti-coagulant isolation
DE3784555D1 (de) Isolierung von bioaktivem, monomerem wachstumshormon.
ATE113062T1 (de) Throminbindende substanz und verfahren zu ihrer herstellung.
Derechin et al. Further studies with human plasminogen
IE38688L (en) Purification of orgotein
KR960031478A (ko) 유비퀴틴 융합 인간 칼시토닌의 정제방법
HUP9903078A2 (hu) Eljárás rekombináns, nem-lipidezett Osp-protein előállítására és tisztítására
KR970070017A (ko) 재조합 인 과립구 콜로니 자극인자(rhG-CSF)의 정제방법
GB1440998A (en) Tuberculin active proteins and peptides